Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Metanovas Biotech

Metanovas is a provider of an AI-enabled drug and disease discovery platform
2021
Nov-50
11-50
Shanghai, China
  • Drug Discovery and Development
  • Personalized Medicine Technologies

Innovation

Industry Problem

Drug discovery teams face slow hypothesis generation and fragmented scientific data analysis.

R&D Focus

Artificial intelligence for drug discovery, disease research and scientific knowledge synthesis.

Innovative Solution

Uses purpose-built AI research agents and computational workflows to support target and therapeutic discovery.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$1.57M

Last Funding Amount

$1.57M

Startup Stage

Early Stage

Lead Investors

Redhill Capital, Sinopharm Capital

People

Founders

CEO

About

Metanovas is a provider of an AI-enabled drug and disease discovery platform

Products

Product

AI-assisted drug and disease discovery platform.

Demo Product or Complete Product?

Early commercial research platform and collaboration stage.

Something missing or incorrect on this page? Help us enrich this information